Log In
Print
BCIQ
Print
Print this Print this
 

NGX-1998

  Manage Alerts
Collapse Summary General Information
Company NeurogesX Inc.
DescriptionTopical liquid formulation of synthetic capsaicinin
Molecular Target Transient receptor potential vanilloid 1 (TRPV1) (VR1)
Mechanism of ActionTransient receptor potential vanilloid 1 (TRPV1) (VR1) agonist
Latest Stage of DevelopmentPhase II
IndicationPain
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today